Evidence map›Paper›PMID 40851531›Full record

ArticleEuropean journal of rheumatology2025

Aseptic Abscess Associated with Ankylosing Spondylitis-Cause or Effect of Therapy? Case Report.

Przemysław Borowy, Karol Urbański, Katarzyna Gołojuch, Patrycja Major, Jakub Smyk, Alicja Kamińska, Bogdan Batko, Joanna Szpor

Abstract read
In one paragraph

Article in European journal of rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Przemysław BorowyDepartment of Rheumatology and Immunology, J. Dietl Hospital, Krakow, Poland.ORCID 0000-0002-6578-0699
Karol UrbańskiDepartment of Rheumatology and Immunology, J. Dietl Hospital, Krakow, Poland.ORCID 0000-0002-7647-9770
Katarzyna GołojuchLudwik Rydygier Memorial Hospital, Kraków, Poland.ORCID 0009-0009-8567-0591
Patrycja Major5th Military Clinical Hospital in Kraków, Kraków, Poland.ORCID 0009-0002-2754-4510
Jakub SmykLudwik Rydygier Memorial Hospital, Kraków, Poland.ORCID 0009-0002-7585-656X
Alicja KamińskaStefan Żeromski Specialist Hospital, Kraków, Poland.ORCID 0009-0007-6393-3405
Bogdan BatkoDepartment of Rheumatology and Immunology, J. Dietl Hospital, Krakow, Poland.ORCID 0000-0003-3999-8093
Joanna SzporDepartment of Pathomorphology, Jagiellonian University Medical College, Kraków, Poland.ORCID 0000-0002-1267-6257

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophil dermatitis is a group of diseases characterized by the leakage of neutrophils in the skin and subcutaneous tissue with a non-infectious, autoinflammatory etiology. These include the aseptic abscess syndrome (AA). Diagnosis is based on histopathological examination and the exclusion of infectious, allergic, and cancer causes. The paper presents the case of a 41-year-old woman with inflammatory spondyloarthropathy (HLA-B27 antigen present), treated with secukinumab, who developed a painful, inflammatory tumor in her right breast. Antibiotic treatment was ineffective, and histopathological exami- nation detected leaching mainly from granulocytes. Infectious and oncological background changes and IgG4+ disease were excluded. After the diagnosis was confirmed, glucocorticoid therapy was started, which brought rapid improvement, but after the dose was reduced, the tumor relapsed. The re-escalation of the steroid dose and the discontinuation of secukinumab coincided with the exacerbation of ankylos- ing spondylitis, which forced the inclusion of upadacitinib, which was effective and well tolerated. Single studies show high efficacy of TNF inhibitors as well as IL-6 or IL-1 blockades in the treatment of AA and sec- ondary prevention in patients with failed steroid therapy. There are no reports of AA cases in the literature during treatment with secukinumab. Treatment with upadacitinib has so far not caused AA recurrence.

Identifiers

PMID40851531
PMCPMC12362505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.